tratamento da giardiase com tinidazol
Clicks: 258
ID: 137556
1975
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
258 views
27 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #68 of 272 articles by views in mobile information systems
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 272 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Estudou-se a eficácia terapêutica do tinidazol, um novo derivado nitroimidazólico, em trinta pacientes com giardiase. A posologia diária foi de 300 mg em 20 pacientes com idade superior a 10 anos, e de 150 mg em 10 crianças com idade inferior a 10 anos. O tratamento teve a duração de cinco dias. O diagnóstico e os controles de cura parasitológicos foram feitos pelos métodos de Hoffman, Pons & Janer e de Faust e cols. Foram realizados três controles, com intervalos de sete dias, iniciando-se na semana subsequente ao término do tratamento. Obtiveram cura parasitológica em 96,6% dos casos. Ressaltam a excelente tolerância da droga, mesmo em pacientes com grave doença fundamental ou em crianças, não se registrando efeitos colaterais. Concluem ser o tinidazol excelente droga giardicida.
The Autors study the therapeutic efficacy of Tinidazole, a new nitrimidazole derivative, in the treatment of thirty patients with giardiasis. They employed the daily dosage of 300 mg for twenty patients and 150 mg for ten children, respectively with ten years of age or and less during five consecutive days. The diagnosis and the parasitological evaluation of the results of treatment were accomplished by stool examinations using zinc sulphate centrifugal-flotation technique of Faust et al. and sedimentatian-concentration technique of Hoffman, Pons and Janer. The control started one week after the treatment and consisted of three stool examinations, at one week intervals. The Authors achieved 96.6 per cent of parasitological cures. They stressed the excellent tolerance of the drug ,even by patients with serious fundamental diseases or by children. No side effects were registered. They conclude that Tinidazole is an excellent drug against Giardia lamblia infections.
The Autors study the therapeutic efficacy of Tinidazole, a new nitrimidazole derivative, in the treatment of thirty patients with giardiasis. They employed the daily dosage of 300 mg for twenty patients and 150 mg for ten children, respectively with ten years of age or and less during five consecutive days. The diagnosis and the parasitological evaluation of the results of treatment were accomplished by stool examinations using zinc sulphate centrifugal-flotation technique of Faust et al. and sedimentatian-concentration technique of Hoffman, Pons and Janer. The control started one week after the treatment and consisted of three stool examinations, at one week intervals. The Authors achieved 96.6 per cent of parasitological cures. They stressed the excellent tolerance of the drug ,even by patients with serious fundamental diseases or by children. No side effects were registered. They conclude that Tinidazole is an excellent drug against Giardia lamblia infections.
| Reference Key |
baranski1975revistatratamento
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Miroslau Constante Baranski;Milton Carneiro Filho;Luiz Alberto Cagliari Santos;Cláudio José Trezub |
| Journal | mobile information systems |
| Year | 1975 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.